| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |